Published in Radiother Oncol on December 01, 2004
A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol (2012) 1.99
Proton beam therapy. Br J Cancer (2005) 1.46
Carbon ion radiotherapy for sacral chordoma. Br J Radiol (2011) 1.27
Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial. BMC Cancer (2011) 0.93
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer (2012) 0.89
MEK-ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death. Cell Death Dis (2010) 0.88
Suppression of E. multilocularis hydatid cysts after ionizing radiation exposure. PLoS Negl Trop Dis (2013) 0.87
Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol (2013) 0.86
Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks. Br J Cancer (2014) 0.85
Proteomics and pathway analysis identifies JNK signaling as critical for high linear energy transfer radiation-induced apoptosis in non-small lung cancer cells. Mol Cell Proteomics (2009) 0.81
Quo vadis radiotherapy? Technological advances and the rising problems in cancer management. Biomed Res Int (2013) 0.78
Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation. J Radiat Res (2015) 0.78
Treatment Parameters Optimization to Compensate for Interfractional Anatomy Variability and Intrafractional Tumor Motion. Front Oncol (2015) 0.78
Carbon ion therapy for early-stage non-small-cell lung cancer. Biomed Res Int (2014) 0.76
On a Rare Cutaneous Metastasis from a Sacrococcygeal Chordoma. Case Rep Pathol (2017) 0.75
Fractionated Radiation Exposure of Rat Spinal Cords Leads to Latent Neuro-Inflammation in Brain, Cognitive Deficits, and Alterations in Apurinic Endonuclease 1. PLoS One (2015) 0.75
Deciphering the Acute Cellular Phosphoproteome Response to Irradiation with X-rays, Protons and Carbon Ions. Mol Cell Proteomics (2017) 0.75
A patient-specific planning target volume used in 'plan of the day' adaptation for interfractional motion mitigation. J Radiat Res (2013) 0.75
Epidemiological study of the incidence of cancers eligible for proton or carbon ions therapy: methodology and results of recruitment estimation. J Cancer Epidemiol (2013) 0.75
Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams. Gene Ther (2015) 0.75
Treatment outcome of ion beam therapy in eight patients with head and neck cancers. Eur Arch Otorhinolaryngol (2016) 0.75
The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC). J Cancer Res Clin Oncol (2016) 0.75
The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams. World J Oncol (2015) 0.75
Measurement of microdosimetric spectra produced from a 290 MeV/n Spread Out Bragg Peak carbon beam. Radiat Environ Biophys (2010) 0.75
Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion (2009) 2.43
HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet (2011) 2.33
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol (2007) 2.29
Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care (2013) 2.15
Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol (2007) 2.03
A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol (2012) 1.99
Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 1.98
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology (2010) 1.71
Particle radiotherapy for prostate cancer. Int J Urol (2014) 1.65
Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer (2005) 1.58
Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol (2004) 1.54
Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer (2004) 1.53
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab (2012) 1.50
Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys (2006) 1.49
Clinical Results of Carbon Ion Radiotherapy at NIRS. J Radiat Res (2007) 1.49
High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population. Metabolism (2011) 1.48
Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res (2010) 1.46
Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol (2002) 1.46
Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol (2012) 1.45
Prognostic significance of unrecognized myocardial infarction detected with MR imaging in patients with impaired fasting glucose compared with those with diabetes. Radiology (2012) 1.44
Mediastinal lymph node staging in potentially resectable non-small cell lung cancer: a prospective comparison of CT and EUS/EUS-FNA. Respiration (2009) 1.42
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41
Villin1, a novel diagnostic marker for cervical adenocarcinoma. Cancer Biol Ther (2009) 1.40
A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol (2010) 1.39
MPO-ANCA-positive slowly progressive glomerulonephritis with focal tuft necrosis and crescents. Intern Med (2002) 1.39
Prognostic factors for regression from impaired glucose tolerance to normal glucose regulation in Japanese patients with nonalcoholic fatty liver disease. Intern Med (2014) 1.39
Physical performance evaluation of a 256-slice CT-scanner for four-dimensional imaging. Med Phys (2004) 1.31
Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.29
Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys (2007) 1.27
Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol (2003) 1.27
Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol (2009) 1.22
Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol (2012) 1.22
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol (2011) 1.21
Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone. Hum Mutat (2008) 1.17
Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res (2006) 1.16
Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma. Cancer Res (2006) 1.16
Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.16
Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Cancer (2012) 1.15
Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys (2004) 1.14
Reproductive history and breast cancer risk. Breast Cancer (2012) 1.14
Current advancement in radiation therapy for uterine cervical cancer. J Radiat Res (2010) 1.14
Carbon-ion radiation therapy for prostate cancer. Int J Urol (2012) 1.13